Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec SE    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Evotec : to report first quarter 2020 results on 14 May 2020

share with twitter share with LinkedIn share with facebook
05/07/2020 | 06:04am EDT
Evotec SE to report first quarter 2020 results on 14 May 2020

Hamburg, Germany, 07 May 2020:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report its financial results for the first quarter of 2020 on Thursday, 14 May 2020.

The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. Furthermore, the Management Board will present an outlook for the fiscal year 2020. The conference call will be held in English.

Conference call details

Date: Thursday, 14 May 2020

Time: 02.00 pm CEST (08.00 am EDT, 01.00 pm BST)

From Germany: +49 69 201 744 220
From France: +33 170 709 502
From Italy: +39 02 3600 6663
From the UK: +44 20 3009 2470
From the USA: +1 877 423 0830

Access Code: 57615818#

A simultaneous slide presentation for participants dialling in via phone is available at https://webcasts.eqs.com/evotec20200514/no-audio.

Webcast details

To join the audio webcast and to access the presentation slides you will find a link on our home page www.evotec.com shortly before the event.

A replay of the conference call will be available for seven days after the conference and can be accessed in Europe by dialling +49 69 20 17 44 221 (Germany) or +44 20 3364 5150 (UK) and in the USA by dialling +1 844 307 9362. The access code is 315586222#. The on-demand version of the webcast will be available on our website: https://www.evotec.com/financial-reports.

FORWARD LOOKING STATEMENTS

Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.

TOP

Disclaimer

Evotec SE published this content on 07 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 May 2020 10:03:06 UTC

share with twitter share with LinkedIn share with facebook
Latest news on EVOTEC SE
07/08EVOTEC : Initiates 'campus curie' in toulouse
EQ
07/01EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
06/30EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities T..
EQ
06/24EVOTEC : Samsara Biocapital, and KCK launch Autobahn Labs
PU
06/24EVOTEC : Samsara biocapital, and kck launch autobahn labs
EQ
06/23EVOTEC : Buy rating from Baader Bank
MD
06/23EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
06/17EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
06/16EVOTEC : virtual Annual General Meeting 2020 approves all proposed agenda items
PU
06/16EVOTEC : Virtual annual general meeting 2020 approves all proposed agenda items
EQ
More news
Financials
Sales 2020 464 M 524 M 524 M
Net income 2020 37,2 M 42,0 M 42,0 M
Net cash 2020 2,00 M 2,26 M 2,26 M
P/E ratio 2020 94,9x
Yield 2020 -
Capitalization 3 588 M 4 059 M 4 053 M
EV / Sales 2019
EV / Sales 2020 7,72x
Nbr of Employees 3 030
Free-Float 89,9%
Chart EVOTEC SE
Duration : Period :
Evotec SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC SE
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 29,10 €
Last Close Price 23,73 €
Spread / Highest target 34,9%
Spread / Average Target 22,6%
Spread / Lowest Target 18,0%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Craig L. Johnstone Chief Operating Officer & Member-Management Board
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC SE2.95%4 059
LONZA GROUP52.43%42 546
CELLTRION, INC.79.28%36 149
SEATTLE GENETICS, INC.52.59%30 180
IQVIA HOLDINGS INC.-7.66%27 247
MODERNA, INC.220.09%24 344